Annette Langer-Gould to Neoplasms
This is a "connection" page, showing publications Annette Langer-Gould has written about Neoplasms.
Connection Strength
0.126
-
Cancer Risk for Fingolimod, Natalizumab, and Rituximab in Multiple Sclerosis Patients. Ann Neurol. 2020 05; 87(5):688-699.
Score: 0.126